HER2 and HER3 expression during neoadjuvant treatment of HER2‐negative early breast cancer: potential for biomarker‐driven sequencing of T‐DXd and HER3‐DXd
- DOI
- 10.1002/cac2.12657
- Published
- 2025-01-06
- Container
- Cancer Communications
- Publisher
- American Association for the Advancement of Science (AAAS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/cac2.12657,
title = {HER2 and HER3 expression during neoadjuvant treatment of HER2‐negative early breast cancer: potential for biomarker‐driven sequencing of T‐DXd and HER3‐DXd},
author = {Christian Fridolin Singer and Stephan Wenzel Jahn and Dominik Hlauschek and Ulrike Maria Heber and Charlotte Mang‐Manger and Daniel Egle and Marija Balic and Angelika Pichler and Georg Pfeiler and Stephanie Kacerovsky‐Strobl and Christoph Suppan and Magdalena Ritter and Edgar Petru and Richard Greil and Zsuzsanna Bago‐Horvath and Christine Deutschmann and Günther Georg Steger and Michael Seifert and Florian Fitzal and Rupert Bartsch and Anu Santhanagopal and Jana Machacek‐Link and Dalila Sellami and Magdalena Schwarz and Christian Fesl and Lidija Sölkner and Stephen Esker and Martin Filipits and Michael Gnant and Unknown},
year = {2025},
journal = {Cancer Communications},
doi = {10.1002/cac2.12657},
url = {https://doi.org/10.1002/cac2.12657}
}RIS
TY - JOUR TI - HER2 and HER3 expression during neoadjuvant treatment of HER2‐negative early breast cancer: potential for biomarker‐driven sequencing of T‐DXd and HER3‐DXd AU - Christian Fridolin Singer AU - Stephan Wenzel Jahn AU - Dominik Hlauschek AU - Ulrike Maria Heber AU - Charlotte Mang‐Manger AU - Daniel Egle AU - Marija Balic AU - Angelika Pichler AU - Georg Pfeiler AU - Stephanie Kacerovsky‐Strobl AU - Christoph Suppan AU - Magdalena Ritter AU - Edgar Petru AU - Richard Greil AU - Zsuzsanna Bago‐Horvath AU - Christine Deutschmann AU - Günther Georg Steger AU - Michael Seifert AU - Florian Fitzal AU - Rupert Bartsch AU - Anu Santhanagopal AU - Jana Machacek‐Link AU - Dalila Sellami AU - Magdalena Schwarz AU - Christian Fesl AU - Lidija Sölkner AU - Stephen Esker AU - Martin Filipits AU - Michael Gnant AU - Unknown PY - 2025 JO - Cancer Communications DO - 10.1002/cac2.12657 UR - https://doi.org/10.1002/cac2.12657 ER -
APA
Singer, C. F., Jahn, S. W., Hlauschek, D., Heber, U. M., Mang‐Manger, C., Egle, D., Balic, M., Pichler, A., Pfeiler, G., Kacerovsky‐Strobl, S., Suppan, C., Ritter, M., Petru, E., Greil, R., Bago‐Horvath, Z., Deutschmann, C., Steger, G. G., Seifert, M., Fitzal, F., Bartsch, R., Santhanagopal, A., Machacek‐Link, J., Sellami, D., Schwarz, M., Fesl, C., Sölkner, L., Esker, S., Filipits, M., Gnant, M., & Unknown (2025). HER2 and HER3 expression during neoadjuvant treatment of HER2‐negative early breast cancer: potential for biomarker‐driven sequencing of T‐DXd and HER3‐DXd. Cancer Communications. https://doi.org/10.1002/cac2.12657
Source records
- crossref · retrieved 2026-09-26T12:41:12.094Z